Use of prophylactic antivirals and care home characteristics associated with influenza in care homes with confirmed outbreaks.
Sign Up to like & getrecommendations! Published in 2019 at "Public health"
DOI: 10.1016/j.puhe.2019.07.018
Abstract: OBJECTIVES To assess the association of antiviral prophylaxis and care home characteristics with the spread and severity of influenza-like illness in care homes with influenza outbreaks in North West England in the 2017/2018 influenza season.… read more here.
Keywords: prophylaxis; home characteristics; antiviral prophylaxis; care home ... See more keywords
1569. Incidence, Risk Factors, and Impact of Antiviral Prophylaxis Duration on Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative [D+R−] Orthotopic Heart Transplant Recipients (OHTR)
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1397
Abstract: Abstract Background CMV disease is a major cause of morbidity and mortality in OHTR, especially among D+R− patients. Clinical trials of longer antiviral prophylaxis have shown reduced CMV disease incidence in kidney and lung transplant… read more here.
Keywords: risk; cmv disease; antiviral prophylaxis; disease ... See more keywords
Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/tp.0000000000002115
Abstract: Background Late cytomegalovirus (CMV) infection can occur after cessation of viral prophylaxis in kidney transplant recipients, yet, timing of infection is unclear and longer duration of prophylaxis may be warranted. Methods We conducted a retrospective… read more here.
Keywords: incidence; cmv; antiviral prophylaxis; transplant ... See more keywords
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.
Sign Up to like & getrecommendations! Published in 2018 at "Blood advances"
DOI: 10.1182/bloodadvances.2018016493
Abstract: Patients treated with allogeneic hematopoietic cell transplantation (HCT) are at risk of cytomegalovirus (CMV) reactivation and disease, which results in increased morbidity and mortality. Although universal antiviral prophylaxis against CMV improves outcomes in solid organ… read more here.
Keywords: cmv; infection; allogeneic hematopoietic; antiviral prophylaxis ... See more keywords
Hepatitis B reactivation with TNF-α inhibitors: assessing antiviral prophylaxis efficacy — protocol for systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2025 at "Systematic Reviews"
DOI: 10.1186/s13643-025-02923-y
Abstract: The widespread use of TNF-α inhibitors (infliximab, adalimumab, golimumab, certolizumab pegol, and etanercept) in gastrointestinal, rheumatologic, and dermatologic disorders raises concerns about hepatitis B reactivation (HBVr). The exact risk remains unclear due to the variability… read more here.
Keywords: tnf; antiviral prophylaxis; systematic review; risk ... See more keywords
Hepatitis B sero-prevalence among hematology patients: importance of Anti-HbcAb and efficiency of antiviral prophylaxis
Sign Up to like & getrecommendations! Published in 2022 at "African Health Sciences"
DOI: 10.4314/ahs.v22i3.60
Abstract: Objectives Hepatitis B infection is an important problem in immune suppressed patients. Anti HbcAb is an important marker that shows past exposure to virus. In this study, we retrospectively searched HBV serology among the patients… read more here.
Keywords: efficiency antiviral; antiviral prophylaxis; anti hbcab; hematology ... See more keywords